Opko Health (OPK) Non-Current Assets (2010 - 2026)
Opko Health's (OPK) quarterly Non-Current Assets came in at $1.3 billion in Q2 2026, down 4.35% YoY from $1.4 billion in Q2 2025, and up 0.59% on a QoQ basis from $1.3 billion in Q1 2026.
Opko Health (OPK) Non-Current Assets (2010 - 2026) Analysis & Trends
Opko Health (OPK) has 17 years of Non-Current Assets data on file, last reported at $1.3 billion in Q2 2026.
- Quarterly Non-Current Assets fell 4.35% year-over-year to $1.3 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $5.4 billion (down 9.69% YoY) and the FY2025 annual result came in at $1.4 billion, down 12.23% from the prior year.
- Non-Current Assets rose to $1.3 billion in Q2 2026, from $1.3 billion in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $1.9 billion in Q2 2022 to a low of $1.3 billion in Q1 2026.
- A 5-year average of $1.6 billion and a median of $1.6 billion in 2024 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2022 — Non-Current Assets retreated 19.15% — and 2023, when it rose 13.55%.
- Tracing OPK's Non-Current Assets over 5 years: stood at $1.8 billion in 2022, then slipped by 3.98% to $1.7 billion in 2023, then declined by 9.64% to $1.5 billion in 2024, then fell by 12.23% to $1.4 billion in 2025, then decreased by 1.54% to $1.3 billion in 2026.
- The last three Non-Current Assets figures came in at $1.3 billion (Q2 2026), $1.3 billion (Q1 2026), and $1.4 billion (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 89.81 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 78.99 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 998.55 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 8.30 Bn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 23.66 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 1.93 Bn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 3.82 Bn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 2.32 Bn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 14.72 Bn |
| 10 | Opko Health | 1.13 Bn | 824.59 Mn | 80.02 Mn | 1.33 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.33 Bn |
| Mar 31, 2026 | 1.32 Bn |
| Dec 31, 2025 | 1.35 Bn |
| Sep 30, 2025 | 1.37 Bn |
| Jun 30, 2025 | 1.39 Bn |
| Mar 31, 2025 | 1.39 Bn |
| Dec 31, 2024 | 1.54 Bn |
| Sep 30, 2024 | 1.63 Bn |
| Jun 30, 2024 | 1.62 Bn |
| Mar 31, 2024 | 1.58 Bn |
| Dec 31, 2023 | 1.70 Bn |
| Sep 30, 2023 | 1.70 Bn |
| Jun 30, 2023 | 1.73 Bn |
| Mar 31, 2023 | 1.76 Bn |
| Dec 31, 2022 | 1.77 Bn |
| Sep 30, 2022 | 1.81 Bn |
| Jun 30, 2022 | 1.87 Bn |
| Mar 31, 2022 | 1.55 Bn |
| Dec 31, 2021 | 1.58 Bn |
| Sep 30, 2021 | 1.86 Bn |